A technical help webinar shall be held for potential candidates of the next Discover of Funding Alternative (NOFO): Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required) . Nationwide Institute of Psychological Well being workers shall be out there to reply questions associated to this NOFO. Potential candidates can take part within the webinar and are inspired to submit their questions or feedback to the Company Contacts listed in Part VII of this NOFO one week earlier than the webinar. Participation within the webinar is neither required nor needed for a profitable utility. A recording of the webinar shall be out there afterward.
The aim of this NOFO is to assist one scientific trial community to guage organic, digital, cognitive, and scientific final result measures in people at scientific excessive threat (CHR) for psychosis in Proof of Precept (PoP) trial(s) utilizing a pharmacological intervention. Distinctive drug improvement instruments developed by AMP® SCZ initiative shall be evaluated within the PoP trial(s). The compound(s) chosen for testing by the AMP SCZ Steering Committee will have an effect on a pathophysiologically related mechanism and have the potential to provide a detectable sign on organic, digital, cognitive, or scientific final result measures inside a 12-16 week interval of examine.
Division of Translational Analysis
No registration is required for this occasion.
Jonathan Sabbagh, Ph.D.
- The webinar shall be held by way of Zoom. Zoom particulars:
- Be a part of ZoomGov Meeting
- Assembly ID: 161 989 8117
- Passcode: 270342
- Dial by your location:
+1 669 254 5252 US (San Jose)
+1 646 828 7666 US (New York)
+1 551 285 1373 US
+1 669 216 1590 US (San Jose)
- People who want deciphering companies and different affordable lodging to take part on this occasion ought to contact Jonathan Sabbagh, Ph.D., at [email protected]. Requests must be made 5 days prematurely of the occasion.